Phathom Pharmaceuticals had a revenue of 58.30M in the quarter ending Mar 31, 2026, with 1.25%. This bring the company's revenue in the last twelve months to 204.89M, Decreased 17.01%. In the fiscal year ending Dec 31, 2025, Phathom Pharmaceuticals had annual revenue of 175.11M with 216.93% growth.